Institutional investors purchased a net $4.8 million shares of EW during the quarter ended December 2013 and now own 94.45% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BOSTON TRUST & INVESTMENT MANAGE... Bought 10.6 Thousand shares of Edwards Lifesciences Corp